Skip to main content
. 2021 Feb 28;18(2):123–134. doi: 10.11909/j.issn.1671-5411.2021.02.003

3. In-hospital clinical outcomes in the propensity score-matched cohort.

Non-thrombocytopenia
(n = 167, DPC ≤ 50%)
Thrombocytopenia
(n = 167, DPC > 50%)
P-value Adjusted OR 95% CI P-value
Data are presented as n (%). *Presented as median (interquartile range). CI: confidence interval; DPC: drop in platelet count; ICU: intensive care unit; LOS: length of stay; OR: odds ratio.
Clinical outcomes
 In-hospital mortality 35 (21.0%) 40 (24.0%) 0.583 0.76 0.37−1.56 0.448
 In-ICU mortality 31 (18.6%) 35 (21.0%) 0.671 0.74 0.34−1.63 0.459
 Major bleeding 37 (22.2%) 66 (39.5%) 0.001 2.54 1.54−4.17 < 0.001
 Hospital LOS, day 7.36 (3.77−10.42)* 9.71 (6.36−16.81)* < 0.001
 ICU LOS, day 2.83 (1.63−4.88)* 5.13 (2.96−9.67)* < 0.001
Other clinical complications
 Transfusion 15 (9.0%) 26 (15.6%) 0.091 2.22 1.05−4.70 0.036
  Transfusion of red blood cell 15 (9.0%) 25 (15.0%) 0.123 2.01 0.96−4.24 0.066
  Transfusion of platelet 4 (2.4%) 6 (3.6%) 0.688
 Tromboembolic events 2 (1.2%) 2 (1.2%) 1.000
 Post-procedural renal insufficiency 27 (16.2%) 57 (34.1%) 0.001 3.04 1.76−5.27 < 0.001
 Dialysis 5 (3.0%) 21 (12.6%) 0.002 7.58 2.18−26.30 0.001
 Mechanical ventilation 70 (41.9%) 92 (55.1%) 0.020 1.89 1.19−2.98 0.007